Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 4900-4999

4900. N. Kipshidze, J.W. Moses, M.B. Leon, “Paclitaxel-coated stent: is there a light at the end of the tunnel?” J. Am. Coll. Cardiol. 38(July 2001):292-293.

4901. A. Farb, P.F. Heller, S. Shroff, L. Cheng, F.D. Kolodgie, A.J. Carter, D.S. Scott, J. Froehlich, R. Virmani, “Pathological analysis of local delivery of paclitaxel via a polymer-coated stent,” Circulation 104(24 July 2001):473-479.

4902. M.K. Hong, R. Kornowski, O. Bramwell, A.O. Ragheb, M.B. Leon, “Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model,” Coron. Artery Dis. 12(September 2001):513-515.

4903. S. Yasuda, T. Noguchi, M. Gohda, T. Arai, N. Tsutsui, Y. Nakayama, T. Matsuda, H. Nonogi, “Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model,” Cardiovasc. Res. 53(1 February 2002):481-486; M. Sturek, H.K. Reddy, “New tools for prevention of restenosis could decrease the ‘oculo-stento’ reflex,” Cardiovasc. Res. 53(1 February 2002):292-293.

4904. Y. Honda, E. Grube, L.M. de La Fuente, P.G. Yock, S.H. Stertzer, P.J. Fitzgerald, “Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system,” Circulation 104(24 July 2001):380-383.

4905. A.M. Lincoff, J.G. Furst, S.G. Ellis, R.J. Tuch, E.J. Topol, “Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model,” J. Am. Coll. Cardiol. 29(15 March 1997):808-816; S.H. Park, A.M. Lincoff, “Anti-inflammatory stent coatings: dexamethasone and related compounds,” Semin. Interv. Cardiol. 3(September-December 1998):191-195.

4906. S. Yasuda, T. Noguchi, M. Gohda, T. Arai, N. Tsutsui, T. Matsuda, H. Nonogi, “Single low-dose administration of human recombinant hepatocyte growth factor attenuates intimal hyperplasia in a balloon-injured rabbit iliac artery model,” Circulation 101(30 May 2000):2546-2549;

4907. J.R. Laird, A.J. Carter, W.M. Kufs, T.G. Hoopes, A. Farb, S.H. Nott, R.E. Fischell, D.R. Fischell, R. Virmani, T.A. Fischell, “Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent,” Circulation 93(1 February 1996):529-536;

4908. A. Farb, A.L. Tang, S. Shroff, W. Sweet, R. Virmani, “Neointimal responses 3 months after (32)P beta-emitting stent placement,” Int. J. Radiat. Oncol. Biol. Phys. 48(1 October 2000):889-898.

4909. A. Farb, S. Shroff, M. John, W. Sweet, R. Virmani, “Late arterial responses (6 and 12 months) after (32)P beta-emitting stent placement: sustained intimal suppression with incomplete healing,” Circulation 103(10 April 2001):1912-1919.

4910. G. Tepe, L.M. Dinkelborg, U. Brehme, P. Muschick, B. Noll, T. Dietrich, A. Greschniok, A. Baumbach, C.D. Claussen, S.H. Duda, “Prophylaxis of restenosis with (186)Re-labeled stents in a rabbit model,” Circulation 104(24 July 2001):480-485.

4911. M. John, S. Shroff, A. Farb, R. Virmani, “Local arterial responses to 32P beta-emitting stents,” Cardiovasc. Radiat. Med. 2(July-September 2001):143-150.

4912. A.J. Taylor, P.D. Gorman, A. Farb, T.G. Hoopes, R. Virmani, “Long-term coronary vascular response to (32)P beta-particle-emitting stents in a canine model,” Circulation 100(7 December 1999):2366-2372;

4913. J.M. Schierholz, J. Beuth, “Sophisticated medical devices as local drug-delivery systems,” Med. Device Technol. 11(March 2000):12-14, 16-17.

4914. M. Holcik, H. Gibson, R.G. Korneluk, “XIAP: apoptotic brake and promising therapeutic target,” Apoptosis 6(August 2001):253-261.

4915. F. Walter, J. Putz, R. Giege, E. Westhof, “Binding of tobramycin leads to conformational changes in yeast tRNA(Asp) and inhibition of aminoacylation,” EMBO J. 21(15 February 2002):760-768.

4916. T. Uchiumi, R. Kominami, “A functional site of the GTPase-associated center within 28S ribosomal RNA probed with an anti-RNA autoantibody,” EMBO J. 13(15 July 1994):3389-3394.

4917. A.C. Gingras, B. Raught, S.P. Gygi, A. Niedzwiecka, M. Miron, S.K. Burley, R.D. Polakiewicz, A. Wyslouch-Cieszynska, R. Aebersold, N. Sonenberg, “Hierarchical phosphorylation of the translation inhibitor 4E-BP1,” Genes Dev. 15(1 November 2001):2852-2864.

4918. S. Pestka, B.L. Daugherty, V. Jung, K. Hotta, R.K. Pestka, “Anti-mRNA: specific inhibition of translation of single mRNA molecules,” Proc. Natl. Acad. Sci. (USA) 81(December 1984):7525-7528; B.L. Daugherty, K. Hotta, C. Kumar, Y.H. Ahn, J.D. Zhu, S. Pestka, “Antisense RNA: effect of ribosome binding sites, target location, size, and concentration on the translation of specific mRNA molecules,” Gene Anal. Tech. 6(January-February 1989):1-16.

4919. J.D. Ahn, R. Morishita, Y. Kaneda, K.U. Lee, J.Y. Park, Y.J. Jeon, H.S. Song, I.K. Lee, “Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells,” Diabetologia 44(June 2001):713-720.

4920. M. Futamura, S. Kamiya, M. Tsukamoto, A. Hirano, Y. Monden, H. Arakawa, S. Nishimura, “Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells,” Oncogene 20(11 October 2001):6724-6730.

4921. T.J. Huang, I.M. Adcock, K.F. Chung, “A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat,” Br. J. Pharmacol. 134(November 2001):1029-1036.

4922. J.S. Clegg, P. Seitz, W. Seitz, C.F. Hazlewood, “Cellular responses to extreme water loss: the water-replacement hypothesis,” Cryobiology 19(June 1982):306-316.

4923. J.S. Clegg, E.P. Gordon, “Respiratory metabolism of L-929 cells at different water contents and volumes,” J. Cell Physiol. 124(August 1985):299-304.

4924. J.L. Mansell, J.S. Clegg, “Cellular and molecular consequences of reduced cell water content,” Cryobiology 20(October 1983):591-612.

4925. J.S. Clegg, S.A. Jackson, K. Fendl, “Effects of reduced cell volume and water content on glycolysis in L-929 cells,” J. Cell Physiol. 142(February 1990):386-391.

4926. S. Eskelinen, P. Saukko, “Effects of glutaraldehyde and critical point drying on the shape and size of erythrocytes in isotonic and hypotonic media,” J. Microsc. 130(April 1983):63-71.

4927. V. Mattimore, J.R. Battista, “Radioresistance of Deinococcus radiodurans: functions necessary to survive ionizing radiation are also necessary to survive prolonged desiccation,” J. Bacteriol. 178(February 1996):633-637;

4928. D. Billi, D.J. Wright, R.F. Helm, T. Prickett, M. Potts, J.H. Crowe, “Engineering desiccation tolerance in Escherichia coli,” Appl. Environ. Microbiol. 66(April 2000):1680-1684;

4929. A. Garcia De Castro, H. Bredholt, A.R. Strom, A. Tunnacliffe, “Anhydrobiotic engineering of gram-negative bacteria,” Appl. Environ. Microbiol. 66(September 2000):4142-4144;

4930. M. Potts, “Desiccation tolerance of prokaryotes,” Microbiol. Rev. 58(December 1994):755-805; P.S. de-Araujo, “The role of trehalose in cell stress,” Braz. J. Med. Biol. Res. 29(July 1996):873-875; C.L. Paiva, A.D. Panek, “Biotechnological applications of the disaccharide trehalose,” Biotechnol. Annu. Rev. 2(1996):293-314; J. Bradbury, “Of tardigrades, trehalose, and tissue engineering,” Lancet 358(4 August 2001):392.

4931. C.S. Cox, “Roles of water molecules in bacteria and viruses,” Orig. Life Evol. Biosph. 23(February 1993):29-36.

4932. D.B. Roszak, R.R. Colwell, “Survival strategies of bacteria in the natural environment,” Microbiol. Rev. 51(September 1987):365-379; M.L. Tamplin, A.L. Gauzens, A. Huq, D.A. Sack, R.R. Colwell, “Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters,” Appl. Environ. Microbiol. 56(June 1990):1977-1980; J.W. Carroll, M.C. Mateescu, K. Chava, R.R. Colwell, A.K. Bej, “Response and tolerance of toxigenic Vibro cholerae O1 to cold temperatures,” Antonie Van Leeuwenhoek 79(September 2001):377-384. See also: Sonia Arbona, Shannon Crum, “Medical geography and cholera in Peru,” Department of Geography, University of Colorado at Boulder, 18 March 1996;; John Tibbetts, “Ocean commotion,” Environ. Health Perspect. 104(April 1996):380-385;; Laurie Garrett, The Coming Plague, Penguin Books USA, New York, 1994, p. 564.

4933. Gregory M. Fahy, “Cryobiology: The Study of Life and Death at Low Temperatures”;

4934. J.G. Linner, S.A. Livesley, “Low temperature molecular distillation drying of cryofixed biological samples,” in J.J. McGrath, K.R. Diller, eds., Low Temperature Biotechnology: Emerging Applications and Engineering Contributions, Amer. Soc. Mech. Engineering, New York, 1988, pp. 147-157.

4935. S.L. Gordon, S.R. Oppenheimer, A.M. Mackay, J. Brunnabend, I. Puhlev, F. Levine, “Recovery of human mesenchymal stem cells following dehydration and rehydration,” Cryobiology 43(September 2001):182-187.

4936. I. Puhlev, N. Guo, D.R. Brown, F. Levine, “Desiccation tolerance in human cells,” Cryobiology 42(May 2001):207-217.

4937. J.H. Crowe, A.F. Cooper Jr., “Cryptobiosis,” Scientific American 225(1971):30-36.

4938. J.H. Crowe, L.M. Crowe, “Water and carbohydrate interactions with membranes: studies with infrared spectroscopy and differential scanning calorimetry methods,” Methods Enzymol. 127(1986):696?703.

4939. A. Garcia de Castro, A. Tunnacliffe, “Intracellular trehalose improves osmotolerance but not desiccation tolerance in mammalian cells,” FEBS Lett. 487(29 December 2000):199-202; A. Tunnacliffe, A. Garcia de Castro, M. Manzanera, “Anhydrobiotic engineering of bacterial and Mammalian cells: is intracellular trehalose sufficient?” Cryobiology 43(September 2001):124-132.

4940. N. Guo, I. Puhlev, D.R. Brown, J. Mansbridge, F. Levine, “Trehalose expression confers desiccation tolerance on human cells,” Nat. Biotechnol. 18(February 2000):168-171, 145-146 (comment); 18(May 2000):473 (comment).

4941. G.W. Brodland, J.H. Veldhuis, “Computer simulations of mitosis and interdependencies between mitosis orientation, cell shape and epithelia reshaping,” J. Biomech. 35(May 2002):673-681.

4942. Marina Chicurel, “Cell migration research is on the move,” Science 295(25 January 2002):606-609;

4943. K.F. Ferri, E. Jacotot, P. Leduc, M. Geuskens, D.E. Ingber, G. Kroemer, “Apoptosis of syncytia induced by the HIV-1-envelope glycoprotein complex: influence of cell shape and size,” Exp. Cell Res. 261(25 November 2000):119-126.

4944. B. Swynghedauw, C. Delcayre, “Biology of cardiac overload,” Pathobiol. Annu. 12(1982):137-183.

4945. T.J. Ryan, “Biochemical consequences of mechanical forces generated by distention and distortion,” J. Am. Acad. Dermatol. 21(July 1989):115-130.

4946. N. Hatta, M. Takata, S. Kawara, T. Hirone, K. Takehara, “Tape stripping induces marked epidermal proliferation and altered TGF-alpha expression in non-lesional psoriatic skin,” J. Dermatol. Sci. 14(February 1997):154-161.

4947. J. Lamote, G. Willems, “DNA synthesis, cell proliferation index in normal and abnormal gallbladder epithelium,” Microsc. Res. Tech. 38(15 September 1997):609-615.

4948. M.W. Otter, K.J. McLeod, C.T. Rubin, “Effects of electromagnetic fields in experimental fracture repair,” Clin. Orthop. 355(October 1998):S90-S104.

4949. Y. Van Nieuwenhove, D. Chen, G. Willems, “Postprandial cell proliferation in the esophageal epithelium of rats,” Regul. Pept. 97(2 March 2001):131-137.

4950. S. Egginton, A.L. Zhou, M.D. Brown, O. Hudlicka, “Unorthodox angiogenesis in skeletal muscle,” Cardiovasc. Res. 49(16 February 2001):634-646.

4951. J. Camacho, A. Sanchez, W. Stuhmer, L.A. Pardo, “Cytoskeletal interactions determine the electrophysiological properties of human EAG potassium channels,” Pflugers Arch. 441(December 2000):167-174.

4952. W.H. Goldmann, “Mechanical aspects of cell shape regulation and signaling,” Cell Biol. Int. 26(2002):313-317.

4953. R.E. Lewis Jr., J.M. Cruse, J.V. Richey, “Effects of anesthesia and operation on the classical pathway of complement activation,” Clin. Immunol. Immunopathol. 23(June 1982):666-671.

4954. S.J. Chadwick, R.D. Stanbridge, J.F. Mowbray, H.A. Dudley, “Plasma fibronectin and complement activation in coronary bypass surgery,” Br. J. Surg. 73(September 1986):704-707.

4955. R. Aslan, B. Tunerir, S. Dernek, T. Kural, B. Sevin, I. Kaklikkaya, Z. Manti, “The factors effecting complement activation in open heart surgery,” J. Cardiovasc. Surg. (Torino) 33(November-December 1992):754-760.

4956. P. Garred, E. Fosse, M.K. Fagerhol, V. Videm, T.E. Mollnes, “Calprotectin and complement activation during major operations with or without cardiopulmonary bypass,” Ann. Thorac. Surg. 55(March 1993):694-699.

4957. J.L. Svennevig, S. Tollofsrud, U. Kongsgaard, H. Noddeland, B. Mohr, M. Ozer, T.E. Mollnes, “Complement activation during and after open-heart surgery is only marginally affected by the choice of fluid for volume replacement,” Perfusion 11(July 1996):326-332.

4958. H. Segal, S. Sheikh, P. Kallis, S. Cottam, C. Beard, D. Potter, E. Townsend, B.P. Bidstrup, M. Yacoub, B.J. Hunt, “Complement activation during major surgery: the effect of extracorporeal circuits and high-dose aprotinin,” J. Cardiothorac. Vasc. Anesth. 12(October 1998):542-547.

4959. A. Tarnok, J. Hambsch, F. Emmrich, U. Sack, J. van Son, W. Bellinghausen, M. Borte, P. Schneider, “Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass,” Pediatr. Cardiol. 20(March-April 1999):113-125.

4960. S. Zhang, Q. Li, S. Yao, “Effect of complement 4 genetic polymorphism on complement activation during cardiopulmonary bypass in open heart surgery among children,” Zhonghua Yi Xue Za Zhi 81(10 August 2001):918-920. In Chinese.

4961. K. Webb, E. Budko, T.J. Neuberger, S. Chen, M. Schachner, P.A. Tresco, “Substrate-bound human recombinant L1 selectively promotes neuronal attachment and outgrowth in the presence of astrocytes and fibroblasts,” Biomaterials 22(May 2001):1017-1028.

4962. T. Khan, S. Sayers, G. Gaik, M. Dauzvardis, “Carbon filaments provide support and directionality to growing rat fetal spinal cord explants,” Neurosci. Lett. 118(16 October 1990):172-176.

4963. J.F. Clemence, J.P. Ranieri, P. Aebischer, H. Sigrist, “Photoimmobilization of a bioactive laminin fragment and pattern-guided selective neuronal cell attachment,” Bioconjug. Chem. 6(July-August 1995):411-417.

4964. D.M. Thompson, H.M. Buettner, “Schwann cell response to micropatterned laminin surfaces,” Tissue Eng. 7(June 2001):247-265.

4965. L. Kam, W. Shain, J.N. Turner, R. Bizios, “Axonal outgrowth of hippocampal neurons on micro-scale networks of polylysine-conjugated laminin,” Biomaterials 22(May 2001):1049-1054.

4966. S. Wang, A.C. Wan, X. Xu, S. Gao, H.Q. Mao, K.W. Leong, H. Yu, “A new nerve guide conduit material composed of a biodegradable poly(phosphoester),” Biomaterials 22(May 2001):1157-1169.

4967. T.C. Holmes, S. de Lacalle, X. Su, G. Liu, A. Rich, S. Zhang, “Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds,” Proc. Natl. Acad. Sci. (USA) 97(6 June 2000):6728-6733;

4968. N. Dubey, P.C. Letourneau, R.T. Tranquillo, “Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties,” Biomaterials 22(May 2001):1065-1075.

4969. S.A. Makohliso, R.F. Valentini, P. Aebischer, “Magnitude and polarity of a fluoroethylene propylene electret substrate charge influences neurite outgrowth in vitro,” J. Biomed. Mater. Res. 27(August 1993):1075-1085.

4970. W. Mayr, M. Bijak, D. Rafolt, S. Sauermann, E. Unger, H. Lanmuller, “Basic design and construction of the Vienna FES implants: existing solutions and prospects for new generations of implants,” Med. Eng. Phys. 23(January 2001):53-60.

4971. M.E. Manwaring, R. Biran, P.A. Tresco, “Characterization of rat meningeal cultures on materials of differing surface chemistry,” Biomaterials 22(December 2001):3155-3168.

4972. T.G. Ruardij, M.H. Goedbloed, W.L. Rutten, “Adhesion and patterning of cortical neurons on polyethylenimine- and fluorocarbon-coated surfaces,” IEEE Trans. Biomed. Eng. 47(December 2000):1593-1599.

4973. E.G. Campioni, J.N. Nobrega, M.V. Sefton, “HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis,” Biomaterials 19(April-May 1998):829-837.

4974. M.S. Chen, J.N. Wu, S.N. Yang, W.Y. Hsieh, J.C. Liu, E. Fu, D.D. Liu, “Free radicals are involved in methylmethacrylate-induced neurotoxicity in human primary neocortical cell cultures,” Chin. J. Physiol. 41(31 December 1998):203-209.

4975. S. Woerly, G.W. Plant, A.R. Harvey, “Neural tissue engineering: from polymer to biohybrid organs,” Biomaterials 17(February 1996):301-310.

4976. G.W. Plant, A.R. Harvey, “A new type of biocompatible bridging structure supports axon regrowth after implantation into the lesioned rat optic tract,” Cell Transplant. 9(November-December 2000):759-772.

4977. N.K. Loh, S. Woerly, S.M. Bunt, S.D. Wilton, A.R. Harvey, “The regrowth of axons within tissue defects in the CNS is promoted by implanted hydrogel matrices that contain BDNF and CNTF producing fibroblasts,” Exp. Neurol. 170(July 2001):72-84.

4978. S. Woerly, R. Marchand, “A century of neurotransplantation in mammals,” Neurochirurgie 36(1990):71-95. In French.

4979. W.F. Tivol, W.F. Agnew, R.B. Alvarez, T.G. Yuen, “Characterization of electrode dissolution products on the high-voltage electron microscope,” J. Neurosci. Methods 19(April 1987):323-337.

4980. M.J. Burton, R.K. Shepherd, G.M. Clark, “Cochlear histopathologic characteristics following long-term implantation. Safety studies in the young monkey,” Arch. Otolaryngol. Head Neck Surg. 122(October 1996):1097-1104.

4981. P. Heiduschka, S. Thanos, “Implantable bioelectric interfaces for lost nerve functions,” Prog. Neurobiol. 55(August 1998):433-461.

4982. H.S. Haggerty, H.S. Lusted, “Histological reaction to polyimide films in the cochlea,” Acta Otolaryngol. 107(January-February 1989):13-22.

4983. T. Lefurge, E. Goodall, K. Horch, L. Stensaas, A. Schoenberg, “Chronically implanted intrafascicular recording electrodes,” Ann. Biomed. Eng. 19(1991):197-207.

4984. K. Kohler, J.A. Hartmann, D. Werts, E. Zrenner, “Histological studies of retinal degeneration and biocompatibility of subretinal implants,” Ophthalmologe 98(April 2001):364-368. In German.

4985. N.S. Peachey, A.Y. Chow, “Subretinal implantation of semiconductor-based photodiodes: progress and challenges,” J. Rehabil. Res. Dev. 36(October 1999):371-376.

4986. E. Guenther, B. Troger, B. Schlosshauer, E. Zrenner, “Long-term survival of retinal cell cultures on retinal implant materials,” Vision Res. 39(December 1999):3988-3994.

4987. M.T. Pardue, E.B. Stubbs Jr., J.I. Perlman, K. Narfstrom, A.Y. Chow, N.S. Peachey, “Immunohistochemical studies of the retina following long-term implantation with subretinal microphotodiode arrays,” Exp. Eye Res. 73(September 2001):333-343.

4988. J.C. Williams, R.L. Rennaker, D.R. Kipke, “Long-term neural recording characteristics of wire microelectrode arrays implanted in cerebral cortex,” Brain Res. Brain Res. Protoc. 4(December 1999):303-313.

4989. J.K. Niparko, R.A. Altschuler, X.L. Xue, J.A. Wiler, D.J. Anderson, “Surgical implantation and biocompatibility of central nervous system auditory prostheses,” Ann. Otol. Rhinol. Laryngol. 98(December 1989):965-970; J.K. Niparko, R.A. Altschuler, D.A. Evans, X.L. Xue, J. Farraye, D.J. Anderson, “Auditory brainstem prosthesis: biocompatibility of stimulation,” Otolaryngol. Head Neck Surg. 101(September 1989):344-352.

4990. D.J. Edell, V.V. Toi, V.M. McNeil, L.D. Clark, “Factors influencing the biocompatibility of insertable silicon microshafts in cerebral cortex,” IEEE Trans. Biomed. Eng. 39(June 1992):635-643.

4991. R.A. Normann, E.M. Maynard, P.J. Rousche, D.J. Warren, “A neural interface for a cortical vision prosthesis,” Vision Res. 39(July 1999):2577-2587.

4992. B.W. Kristensen, J. Noraberg, P. Thiebaud, M. Koudelka-Hep, J. Zimmer, “Biocompatibility of silicon-based arrays of electrodes coupled to organotypic hippocampal brain slice cultures,” Brain Res. 896(30 March 2001):1-17; H. Jahnsen, B.W. Kristensen, P. Thiebaud, J. Noraberg, B. Jakobsen, M. Bove, S. Martinoia, M. Koudelka-Hep, M. Grattarola, J. Zimmer, “Coupling of organotypic brain slice cultures to silicon-based arrays of electrodes,” Methods 18(June 1999):160-172.

4993. R.C. deCharms, D.T. Blake, M.M. Merzenich, “A multielectrode implant device for the cerebral cortex,” J. Neurosci. Methods 93(30 October 1999):27-35.

4994. T.G. Yuen, W.F. Agnew, “Histological evaluation of polyesterimide-insulated gold wires in brain,” Biomaterials 16(August 1995):951-956.

4995. M. Huber, P. Heiduschka, S. Kienle, C. Pavlidis, J. Mack, T. Walk, G. Jung, S. Thanos, “Modification of glassy carbon surfaces with synthetic laminin-derived peptides for nerve cell attachment and neurite growth,” J. Biomed. Mater. Res. 41(August 1998):278-288.

4996. J.A. Malmstrom, T.G. McNaughton, K.W. Horch, “Recording properties and biocompatibility of chronically implanted polymer-based intrafascicular electrodes,” Ann. Biomed. Eng. 26(November-December 1998):1055-1064.

4997. T.L. Babb, W. Kupfer, “Phagocytic and metabolic reactions to chronically implanted metal brain electrodes,” Exp. Neurol. 86(November 1984):171-182.

4998. S. Giannetti, L. Lauretti, E. Fernandez, F. Salvinelli, G. Tamburrini, R. Pallini, “Acrylic hydrogel implants after spinal cord lesion in the adult rat,” Neurol. Res. 23(June 2001):405-409.

4999. S. Woerly, V.D. Doan, F. Evans-Martin, C.G. Paramore, J.D. Peduzzi, “Spinal cord reconstruction using NeuroGeltrade mark implants and functional recovery after chronic injury,” J. Neurosci. Res. 66(15 December 2001):1187-1197.


Last updated on 16 April 2004